Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 01/04/2010
PIL Humulin I 100IU suspension for injection in cartridge

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/04/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 16/05/2008 and displayed until 01/04/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 30/01/2008 and displayed until 16/05/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 25/06/2007 and displayed until 30/01/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Extra statutory information
  • Change to date of revision
Updated on 31/01/2006 and displayed until 25/06/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 06/11/2003 and displayed until 31/01/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  human insulin